Versor Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Versor Investments’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-357,259	Closed	-$34.6M	–	403
2019 Q3	$34.6M	Buy	357,259 +128,642	+56%	+$12.9M	2.36%	13
2019 Q2	$23.4M	Buy	228,617 +67,286	+42%	+$7.26M	1.56%	26
2019 Q1	$18.4M	Buy	+161,331	New	+$11.9M	1.75%	25

Versor Investments's ONCE Position: Q4 2019 in Review

Versor Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 357,259 shares — an estimated $34.6M sold.

Versor Investments first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $34.6M in Q3 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

Versor Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Versor Investments sold 357,259 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $34.6M.
Versor Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
Versor Investments's Spark Therapeutics, Inc. Common Stock position peaked at $34.6M in Q3 2019.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Versor Investments's 13F filing for Q4 2019, filed 10 Feb 2020.